art2art

Score Your Organization’s Decision Abilities

Hospira, a specialty pharmaceutical and medical device company headquartered near Chicago, had a pretty good track record in the five years since it was spun off from Abbott Laboratories. Sales had grown to $3.6 billion. Its two primary product lines, generic injectables and medication management systems, were doing well. The company employed fourteen thousand people and had several major facilities in the United States and overseas. Still, CEO Chris Begley felt that Hospira had more potential than ...

Get Decide and Deliver now with the O’Reilly learning platform.

O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.